Efeito do tratamento com dose reduzida do aglepristone em uma hiperplasia mamaria felina: Relato de caso
Silva, Paula Barbosa DaCavalho, Elaine Lopes DeOliveira Neta, Anália Costa DeChaves Neto, ÁlvaroLima, Wilton FigueiredoSilva, Gustavo Alighiere Lopes DaFernandes, Natacha Cintia FerreiraRibeiro, Haroldo Francisco Lobato
Feline mammary hyperplasia (FMH) is a benign condition representing a disorder of body related tonatural or synthetic progestogen characterized by rapid cell growth of one or more mammary glands. Havingrapidly evolving and can cause serious systemic changes, it is necessary to use instant protocols, such as the useof aglepristone an antiprogestogen. This study aims to report a case of FMH with aglepristone-based therapy. Acat mongrel, with 9 months old, nulliparous, who received a contraceptive dose, showed an increase in thethoracic right mammary gland M1. The history and physical examination indicated the diagnosis of FMH. Thetherapy established was aglepristone in 3 doses (10mg / kg) every 24 hours. The result was total remission ofsymptoms. The use of aglepristone proved to be effective in the treatment of FMH even without castration.(AU)
Texto completo